[{"indications": "Indications\u00a0adjuvant treatment of oestrogen-receptor-positive early breast cancer\r\nin postmenopausal women following 2\u20133 years of tamoxifen therapy;\r\nadvanced breast cancer in postmenopausal women in whom anti-oestrogen\r\ntherapy has failed", "name": "EXEMESTANE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.3 Sex hormones and hormone antagonists in malignant disease", "8.3.4 Hormone antagonists", "8.3.4.1 Breast cancer"], "cautions": "Cautions\u00a0interactions: Appendix 1 (exemestane)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, dyspepsia, constipation,\r\nanorexia; dizziness, fatigue, headache, depression, insomnia; hot\r\nflushes, sweating; alopecia, rash; less commonly drowsiness,\r\nasthenia, and peripheral oedema; rarely thrombocytopenia,\r\nleucopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/86293.htm", "doses": ["25\u00a0mg daily"], "pregnancy": "Pregnancy\u00a0avoid"}]